Hélène Pluchart (H Pluchart)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Metastatic Breast Cancer

Respiratory Syncytial Virus

Platelet Rich Plasma

Top Venues

Journal of medical case reports

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hélène Pluchart, Sébastien Bailly, Sébastien Chanoine, Denis Moro-Sibilot, Pierrick Bedouch, Anne-Claire Toffart
Comparison of seven comorbidity scores on four-month survival of lung cancer patients. BMC medical research methodology 23 (1) (2023)
Hélène Pluchart, Sébastien Bailly, Sébastien Chanoine, Denis Moro-Sibilot, Pierrick Bedouch, Anne-Claire Toffart
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients. BMC cancer 23 (1) (2023)
Hélène Pluchart, Sébastien Chanoine, Amandine Briault, Johanna Claustre, Pierrick Bedouch
Restrictive allograft dysfunction after lung transplantation: is there a place for nintedanib?-a case report. Fundamental & clinical pharmacology 34 (3) (2020)
Marion Duwez, Sébastien Chanoine, Marion Lepelley, Ha Thi Vo, Hélène Pluchart, Roseline Mazet, Benoît Allenet, Christophe Pison, Amandine Briault, Christelle Saint-Raymond, Boubou Camara, Johanna Claustre, Pierrick Bedouch
Clinical evaluation of pharmacists' interventions on multidisciplinary lung transplant outpatients' management: results of a 7-year observational study. BMJ open 10 (11) (2020)
Hélène Pluchart, Julian Pinsolle, Julien Cohen, Gilbert R Ferretti, Pierrick Bedouch, Matteo Giaj Levra, Anne-Claire Toffart, Denis Moro-Sibilot
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report. Journal of medical case reports 11 (1) (2017)
Hélène Pluchart, E Jacquet, D Charlety, B Allenet, P Bedouch, M Mousseau
Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer. Targeted oncology 11 (5) (2017)